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ER stress response: Getting the UPR hand on misfolded proteins
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Unfolded proteins are constantly delivered to the ER
lumen, where they must be removed by folding or
degradation. Recent studies show that the ‘unfolded
protein response’ controls essentially all aspects of ER
function, coordinating these two fates for misfolded
proteins in a process necessary for normal cell life.
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The endoplasmic reticulum (ER) orchestrates the synthesis
and processing of nearly all proteins that reside in, or pass
through, the endomembrane system of a eukaryotic cell.
This large group of soluble and membrane proteins is deliv-
ered to the ER as linear polypeptides that each acquire
their final shape by the action of a battery of ER-resident
enzymes and chaperones. The ER lumen thus has a large
and varying concentration of unfolded proteins that are con-
tinuously in need of processing and folding. The impor-
tance of these reactions is underscored by the fact that
many of the ER proteins serving this purpose are essential
for life. The ER is also the site of a robust and broadly used
degradation pathway that recognizes and destroys unfolded
forms of both lumenal and integral membrane proteins, in a
process called ER-associated degradation (ERAD).
Two different fates can thus befall an unfolded protein in
the ER: folding or degradation. The new work featured in
this dispatch [1], and related recent studies [2,3], show
that a master ER surveillance system, called the ‘unfolded
protein response’ (UPR) regulates essentially all aspects of
ER function, and continuously coordinates the activity
and participation of the processing and degradation
pathways for unfolded proteins. The work is instructive in
several ways, revealing a global view of ER physiology,
and convincingly demonstrating the power of combining
genomics and basic functional studies to understand
integrated cellular functions.
UPR — knowin’ when to fold ‘em
Many situations will increase levels of unfolded proteins
in the ER lumen [4]. These include diminished protein
glycosylation caused by starvation or treatment with drugs
such as tunicamycin, increased production of misfolded
mutant proteins or unassembled protein subunits, altered
redox status of the lumen brought about by reducing
agents such as DTT or genetic means, and altered
lumenal ion content caused by ionophores or heavy
metals. The common result of these treatments is a state
of ER stress in which the burden of unfolded proteins
exceeds the capacity of the ER machinery to deal with
them. The ER unfolded protein burden can also vary
widely between different normal cell types: professional
secreting cells like plasma B lymphocytes produce and
process secretory proteins to a far greater extent than cells
with less extroverted occupations. So how does the cell
adjust to changes in the ER unfolded protein burden
brought about by these diverse contingencies? It turns out
that the ER is not just a bag full of chaperones, but
harbors a finely-tuned signaling pathway — the UPR
(Figure 1), which continuously measures and responds to
the ever-changing lumenal levels of unfolded proteins. 
The UPR was first described over 10 years ago [5], with the
observation that mammalian cells respond to ER stresses
by increasing production of ER-resident proteins which
assist protein folding, such as BiP, a member of the heat
shock protein 70 (Hsp70) family of molecular chaperones.
The subsequent demonstration that Kar2p, the yeast BiP
homologue, is similarly regulated opened the genetic door
to understanding conserved aspects of the UPR [6,7]. The
resulting analysis of the UPR, performed by several labora-
tories but principally by Walter and colleagues, has been a
genetic tour de force [8–12]. The details are the subject of
numerous reviews (for example [4,13,14]), and so only
receive brief treatment here, despite the temptation to
retell a spectacular and surprising molecular tale. 
The UPR starts with a transmembrane kinase called Ire1p,
which has a cytosolic domain homologous to the ribonucle-
ase RNaseL and a lumenal domain that somehow senses
unfolded proteins. Earlier yeast studies and very recent
work with mammalian cells support a model in which
sensing is mediated by competition between the Ire1p
lumenal domain and free unfolded proteins for binding to
Kar2p [15,16]. Although the details have not been rigorously
delineated, certainly something like this gets the UPR ball
rolling. The current model rests on the idea that Kar2p
binding inhibits Ire1p from dimerizing and so keeps it inac-
tive. When levels of unfolded proteins increase, they more
effectively compete for Kar2p, allowing the now-free Ire1p
to dimerize and self-activate. Ire1p activation increases pro-
duction of transcription factor Hac1p through non-canonical
splicing of the HAC1 mRNA, accomplished in part by a spe-
cific endonuclease activity of Ire1p cytosolic domain itself
(hence the homology to RNaseL). The resulting increase in
Hac1p then programs the transcription of numerous genes
coding for ER folding and processing factors, including
Kar2p itself. Elegant, effective and very novel.
As odd as this molecular mechanism seems, it is broadly
conserved in eukaryotes [17], although the mammalian
ER stress response is a more complicated affair, involving
regulated cleavage of the Ire1p protein [18], an added
branch to the UPR pathway employing a distinct
transmembrane kinase (PERK) that functions to attenuate
translation [19,20], and separate response pathways that
measure ER stresses distinct from unfolded proteins [4].
UPR globalization — a block off the old chip
The UPR is thus a transcriptional response: when unfolded
proteins in the ER increase, a transcription factor is acti-
vated to increase the expression of needed genes. Just how
many genes does this pathway regulate? A broad role for
the UPR in ER function was indicated by the previous
genetic history of Ire1p. IRE1 was originally isolated in an
earlier screen for genes needed for the production of inosi-
tol — hence its name, derived from Inositol REquiring —
a key precursor for an abundant group of ER membrane
phospholipids [21]. This intriguing connection and subse-
quent studies indicated that the UPR regulates ER mem-
brane structure as well as protein processing capacity [22].
Similarly, a new genetic screen by Ng et al. [2] beautifully
complements the genomic analysis (see below), indepen-
dently demonstrating a broad role for UPR in ER function.
Traditional approaches to identifying transcriptional
targets of the UPR would require a gene-by-gene query.
Instead, Travers et al. [1] capitalized on the advanced state
of yeast genomics to fully characterize the UPR. Like the
genomes of a few other eukaryotes, that of the budding
yeast Saccharomyces cerevisiae has been fully sequenced.
The small size — a bit over 6000 genes — of the yeast
genome and early completion of its sequence has spawned
the development of several related methods for measuring
the whole genome response to physiological or genetic
perturbations (for one most relevant to this work, see [23]).
The basic strategy is now almost rote undergraduate
midterm fare: ‘prepare mRNA from two different conditions
so that each batch is optically distinguishable, hybridize the
mix to a microarray that will bind each message at a distinct
position, and collect the results with optical detection for
computer analysis’. Simple, no? The Travers et al. [1] paper
is a remarkably instructive example of what is required to
actually use this seemingly straightforward approach. A key
to their successful genomic analysis was implementation of
much previously harvested information about the UPR,
obtained by gene-by-gene query, classical genetics and bio-
chemistry, to extend understanding by the array approach.
In the array analysis performed by Travers et al. [1], the
UPR was induced in yeast cells with either DTT or
tunicamycin, drugs that work in very different ways to
induce the UPR, for different times. Separate array
analyses were done (drug versus control) with each drug
at four induction times. Furthermore, two different
UPR-deficient null mutants, ire1D or hac1D, were subject
to similar treatments, so that the response of every yeast
open reading frame to the two drugs was determined in
the presence and absence of a functional UPR pathway.
The responses of each open reading frame were next
compared to those of a group of seven known UPR-regu-
lated genes, and genes with a statistically significant, bio-
logically similar response were ascertained.
The results of this impressive and biologically informed




The unfolded protein response (UPR): a
model for this ER sensing and response
pathway derived from the studies referenced
in the text. When the burden of unfolded
proteins is low, ER chaperone Kar2p binds to
the lumenal domain of the Ire1p protein, thus
limiting Ire1p self-association and activity of
the protein. When the lumenal unfolded
protein burden is increased as a result of
pharmacological, genetic or developmental
perturbation, the Kar2p molecules (and/or
other chaperones) are ‘distracted’ from
binding Ire1p, allowing self-association and
activation of Ire1p. Active Ire1p participates in
splicing of inactive HAC1 mRNA, called
HAC1u, into a form, HAC1i, that is efficiently
translated, allowing production of Hac1p
transcription factor and increased synthesis of
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satisfying and informative. First, it is clear that the UPR
does indeed regulate a large battery of genes that are
involved in many aspects of ER function. These include
representatives of nearly all aspects of ER protein produc-
tion and delivery. To be sure, there are also plenty of
genes with high statistical significance and known non-
ER-related functions. But within this constellation of
UPR-regulated genes is a group required for ER-associ-
ated degradation (ERAD), including HRD1/DER3, HRD3,
DER1 and UBC7. These genes encode parts of a dedi-
cated machinery for the destruction of misfolded lumenal
and membrane proteins by the ubiquitin–proteasome
pathway [24–28]. Thus it appears that the UPR includes
coordinate upregulation of pathways that mediate the two
fates for misfolded ER proteins: folding and export, or
retrotranslocation and degradation (Figure 2).
The ER eats its young — destruction of proteins in the
unstressed ER
The coordinate regulation of folding and degradation com-
ponents divined from genomic analysis suggests a number
of experiments examining the interplay of these processes
[1–3]. The regulation of ERAD components by the UPR
indicates that the ‘tone’ of this pathway could help deter-
mine the rates of ER protein degradation. Indeed, lowering
Hac1p activity by loss of the UPR was found to diminish
the degradation rates of ER proteins — Travers et al. [1]
showed this specifically for the well-characterized ERAD
substrate CPY*, a constitutively misfolded protein, and
heterologously expressed class I major histocompatibility
(MHC) proteins. Conversely, increasing HAC1 expression
with a regulated promoter was found to significantly hasten
CPY* degradation. The UPR-regulation of ERAD may
extend to previously unknown genes, as a null mutation of
a novel UPR-regulated gene, PER100, identified in these
studies does cause a detectable ERAD deficiency, although
the modesty of the phenotype suggests it may be an ancil-
lary or pleiotropic participant in protein destruction.
Further examination of the link between UPR and ERAD
places the degradation of proteins in the center of normal
ER physiology. If the ER deals with unfolded proteins by
a branched pathway of either degradation or folding, then
one might expect that simultaneous removal of these alter-
natives would have serious consequences. Indeed, strains
with null mutations in both IRE1 and any of several ERAD
genes, such as HRD1 or HRD3, grow poorly and die at ele-
vated temperatures. This result also addresses the previ-
ously vexing viability of individual null mutants deficient
in either UPR or ERAD. Using a sensitive green fluores-
cent protein (GFP) reporter for UPR activity, Travers et al.
[1] further showed that loss of ERAD causes a constitu-
tively higher level of UPR-dependant transcription, consis-
tent with earlier observations on null mutants in UBC7, a
key enzyme in the ubiquitination of ERAD substrates [29].
Taken together, these results show that ERAD is occur-
ring all the time, and that its loss results in an elevation
of unfolded proteins substantial enough to be felt by the
ER scanning system. The lethality of the double mutants
means that ERAD is a physiologically important alterna-
tive to the folding and processing pathways provided by
UPR regulation. The synthetic lethality of the UPR- and
ERAD-deficient null mutants also indicates that the two
pathways must function independently to some extent: if
ERAD were totally dependent on the UPR, then loss of
ERAD components in addition to the UPR would be
expected to have no additional phenotypes. 
It has recently been shown that, in mammalian cells, loss
of the translational attenuation mediated by the kinase
PERK, which is on a UPR branch that is specific for
metazoans, similarly has grave consequences for managing
ER stress [20]. Thus, mammalian cells are also sensitive to
an inability to handle newly made proteins, but they have
the added tactic of diminishing their production as a
stress-management tool. Although the interplay of folding
Figure 2
Two fates for unfolded ER proteins controlled
by the UPR. Unfolded proteins in the ER
lumen or the ER membrane can either be
folded (left branch) or degraded by
ER-associated degradation (ERAD), by the
appropriate proteins dedicated to these
functions. An increased level of unfolded
proteins increases the ‘tone’ of the UPR,
causing concomitant increases in activity of
each process. Importantly, the studies with
null mutants indicate that these two fates both
operate continuously in normal cells, such that
loss of capacity to perform either branch
results in measurable cell stress.
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and degradation has not yet been tested in the mammalian
UPR, the conservation of the signaling pathway, the
folding machinery and various ERAD components makes
it likely the URP and ERAD will turn out to be similarly
intertwined across the eukaryotic board.
UPR genomics: the Utility of Previous Results
Besides the broad and useful insights into ER physiology
that emerge from these studies, the work also provides an
instructive and perhaps cautionary tale about the place
and use of genomics in analysis of biological processes.
One hears the most single-minded proponents of genomics
— perhaps those with too much NASDAQ exposure —
state the belief that this approach will herald in a ‘new
biology’ where study of individual proteins, genes and
phenotypes will be supplanted completely by analyses of
large groups of genes with arrays and probably other
future tools we have not yet imagined. Certainly, global
analyses will change biology in big ways, and future
biology will be more of an armchair affair. But what is clear
from the successful study featured above [1] is that an
understanding of the biology and genetics of UPR
informed all aspects of the work. 
The parallel work of Ng et al. [2], who took a more
traditional genetic approach to studying the ‘globality’ of
the UPR, turned up ER-functioning genes that interacted
strongly with UPR mutations but were not regulated by
this transcriptional axis, underscoring the importance of
integrated approaches to studying big problems. These
hallmark studies provide us with a more balanced view of
where the genomic approach fits into current biology. It is
a powerful way to extend our understanding of complex
life processes, in which previous methods and understand-
ing of molecular functions synergize, rather then compete,
with this new avenue of inquiry.
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